Mirada Life Sciences Company Profile
Background
Overview
Mirada Life Sciences is a consulting firm specializing in medical affairs, offering strategic support to pharmaceutical and biotechnology companies. The company combines scientific expertise with a deep understanding of healthcare trends, access landscapes, and clinical breakthroughs to develop impactful, educational, and strategic resources and tools. Their mission is to assist clients in achieving personal and professional excellence by providing tailored solutions that address complex challenges in the medical field.
Mission and Vision
Mirada Life Sciences strives to share scientific expertise combined with an understanding of the latest healthcare trends, access landscape, and clinical breakthroughs to develop impactful, educational, and strategic resources and tools to help clients achieve personal and professional excellence.
Primary Area of Focus
The company focuses on providing consulting services that support medical affairs professionals in the pharmaceutical and biotechnology sectors. Their services include strategic assessments, primary research, medical training, and the development of field-facing presentations and educational materials.
Industry Significance
In the competitive pharmaceutical and biotechnology industries, effective medical affairs are crucial for the successful development and commercialization of medical products. Mirada Life Sciences plays a significant role by equipping medical affairs teams with the necessary tools, training, and strategic insights to navigate complex healthcare environments and deliver value to both clients and patients.
Key Strategic Focus
Core Objectives
Mirada Life Sciences aims to:
- Provide strategic support to medical affairs teams in the pharmaceutical and biotechnology sectors.
- Develop educational and strategic resources that address complex challenges in the medical field.
- Assist clients in achieving personal and professional excellence through tailored solutions.
Specific Areas of Specialization
The company specializes in:
- Strategic assessments to identify unmet needs and develop tailored strategies.
- Primary research, including interactive teleconference interviews with U.S. and global Key Opinion Leaders (KOLs) and Healthcare Professionals (HCPs).
- Medical training and launch preparation, including the development of engagement manuals, interactive training modules, and live training exercises.
Key Technologies Utilized
While specific technologies are not detailed, Mirada Life Sciences emphasizes the integration of scientific expertise with an understanding of healthcare trends, access landscapes, and clinical breakthroughs to develop impactful resources and tools.
Primary Markets or Conditions Targeted
The company primarily targets the pharmaceutical and biotechnology sectors, focusing on medical affairs teams involved in the development and commercialization of medical products. Their services are designed to address challenges across various therapeutic areas, including oncology, neurology, immunology, rare diseases, and infectious diseases.
Financials and Funding
Funding History
Specific details regarding Mirada Life Sciences' funding history are not publicly disclosed.
Total Funds Raised
Information about the total funds raised by Mirada Life Sciences is not publicly available.
Notable Investors
Details about notable investors in Mirada Life Sciences are not publicly disclosed.
Intended Utilization of Capital
The company utilizes its capital to develop and deliver strategic consulting services, educational resources, and training programs that support medical affairs professionals in the pharmaceutical and biotechnology industries.
Pipeline Development
As a consulting firm, Mirada Life Sciences does not have a product pipeline or clinical trials. Instead, they focus on providing strategic support and resources to medical affairs teams in the pharmaceutical and biotechnology sectors.
Technological Platform and Innovation
Proprietary Technologies
While specific proprietary technologies are not detailed, Mirada Life Sciences emphasizes the integration of scientific expertise with an understanding of healthcare trends, access landscapes, and clinical breakthroughs to develop impactful resources and tools.
Significant Scientific Methods
The company employs the ADDIE+M instructional design framework for medical training, adapting content to accommodate visual, auditory, and kinesthetic learning styles.
AI-Driven Capabilities
Specific AI-driven capabilities are not detailed in the available information.
Leadership Team
Key Executive Profiles
- Corinne Cusumano, PhD: With over seven years of pharmaceutical consulting experience and a PhD in microbiology, Dr. Cusumano leads consulting projects involving the development of field-facing presentations and in-depth qualitative and quantitative market research.
- Josh Garcia, MS: With nearly 15 years of pharmaceutical consulting experience across various practice areas, including medical affairs resource development, training, and strategy, Mr. Garcia has a depth of experience in therapeutic areas such as oncology, neurology, immunology, and women's health.
- Eric Miller, PhD: With over ten years of experience in pharmaceutical consulting and seven years in therapeutic start-up and management, Dr. Miller's primary areas of expertise include oncology, immunology, rare diseases, medical devices, and early-stage therapeutic development.
- Maneesh Kumar, MD, PhD: Dr. Kumar combines clinical training with experiences in grantmaking and as a Medical Science Liaison (MSL), leveraging his deep scientific knowledge to craft compelling stories.
- Derek Kellar, PhD: With over three years of consulting experience at Mirada Life Sciences and more than six years in scientific research, Dr. Kellar has developed expertise in areas including oncology, neuroscience, clinical trials, medical imaging, and immunology.
- Emily Rhoads: With over 15 years of pharmaceutical development experience, including nine years in translational and clinical R&D and over six years in medical affairs consulting, Ms. Rhoads' areas of expertise include oncology/hematology, translational science/medicine, and companion diagnostics/precision medicine.
- Patricia Izbicki, PhD: A clinical and cognitive neuroscientist with extensive experience in the biotech and pharmaceutical industries, Dr. Izbicki specializes in neurology, neuromodulation, fluid biomarkers, and precision medicine.
- Adrienne T. Perkins, PhD: Dr. Perkins holds a PhD in Biological Sciences from Dartmouth College and has experience in clinical research, including a postdoctoral fellowship at the National Institutes of Health.
- Katie Henley, PhD: With ten years of experience in health and biomedical sciences, Dr. Henley has created deliverables for a variety of audiences, including scientists, healthcare professionals, patients, students, and the general public.
- Aki Yoneda Kau, PhD: A senior consultant with Mirada for three years, Dr. Kau has developed a unique skill set through years of biomedical research and enjoys using her artistic aptitude to bring creative innovations to clients' needs.
- Benjamin Seitzman, PhD: With two years of pharmaceutical consulting experience and more than ten years of biomedical research experience, Dr. Seitzman has significant experience in oncology, neurology, radiation oncology, psychiatry, pediatrics, and medical devices.
- Sarah Weineck: With over five years of experience in pharmaceutical consulting, Ms. Weineck has developed medical education resources and commercial training materials in oncology, neurology, medical aesthetics, and rare diseases.
- Renee Allison, PharmD, MPH: With extensive experience in health system pharmacy, regulatory affairs, and the life sciences sector, Dr. Allison holds a Doctor of Pharmacy (PharmD) degree and a Master of Public Health (MPH) degree.
- Blake Bruene, PharmD: With five years of experience as a Clinical Research Associate monitoring clinical trials in oncology, Dr. Bruene obtained his PharmD and has expertise in clinical trials, medical and regulatory affairs, pediatrics, oncology, and population health.
Leadership Changes
Specific details regarding recent significant changes or appointments within Mirada Life Sciences' leadership are not publicly disclosed.
Competitor Profile
Market Insights and Dynamics
The pharmaceutical and biotechnology consulting industry is characterized by a growing demand for specialized expertise in medical affairs, strategic assessments, and training programs. Companies like Mirada Life Sciences play a crucial role in supporting medical affairs teams to navigate complex healthcare environments and deliver value to both clients and patients.
